Mallinckrodt PLC is seeking to free itself of opioid litigation by putting its generic unit into Chapter 11 bankruptcy and then paying plaintiffs $1.6bn over eight years through a trust overseen by the bankruptcy court.
A "channeling injunction" is expected to release parent Mallinckrodt from all opioid-related claims that could have been asserted against it...





